Bioclonetics Immunotherapeutics, Inc.

Bioclonetics Immunotherapeutics, Inc. logo via Clearbit

Profile

According to their SEC filings, Bioclonetics Immunotherapeutics, Inc. is a Corporation organized in TX on 12-24-2009. They report having 4 employee(s), and revenue in their most-recent fiscal year of $0.00 and $0.00 the prior year.

Company Description

"A Cure for #HIV in long past due. Invest in and join our #technology https://t.co/5tFsbcAmaw. See our website below for more information."

Website: http://www.bioclonetics.com

Sector: Information Technology

Industry: Internet Software & Services

Twitter: BClonetics

LinkedIn: bioclonetics

Location

1756 BISON MEADOW LANE

HEATH, TX 75032

Equity Crowdfunding Campaigns

Reg CF Offering from Bioclonetics Immunotherapeutics, Inc. (Previous)

Campaign Details

According to their SEC filings, Bioclonetics Immunotherapeutics, Inc. previously ran a Regulation Crowdfunding campaign to raise $10,000.00 (up to a maximum of $683,234.00) in Convertible Note via StartEngine before a deadline of 11-02-2018.

As compensation for managing the offering, StartEngine reported being compensated as follows:

6 percent

In addition to any direct compensation, Bioclonetics Immunotherapeutics, Inc. reported that StartEngine would also receive the following financial interest in the offering:

N/A

Bioclonetics Immunotherapeutics, Inc. filed the following progress report with the SEC at the end of their campaign:

The amount raised at the time of closing is $265,800.

Reg CF Offering from Bioclonetics Immunotherapeutics, Inc. (Previous)

Campaign Details

According to their SEC filings, Bioclonetics Immunotherapeutics, Inc. previously ran a Regulation Crowdfunding campaign to raise $0.00 (up to a maximum of $0.00) in via before a deadline of .

As compensation for managing the offering, reported being compensated as follows:

In addition to any direct compensation, Bioclonetics Immunotherapeutics, Inc. reported that would also receive the following financial interest in the offering:

Bioclonetics Immunotherapeutics, Inc. filed the following progress report with the SEC at the end of their campaign:

The final number is $386,766.00 in investments.

More information about this issuer may also be available via Crowditz.com, including information about weekly and aggregate investor commitments.

Financial Information

The following information is taken directly from SEC filings.

Income Statement Items

Most Recent Fiscal Year Prior Fiscal Year
Revenue $0.00 $0.00
Cost of Goods Sold $0.00 $0.00
Taxes Paid $0.00 $0.00
Net Income $-217,470.00 $-95,511.00

Balance Sheet Items

Most Recent Fiscal Year Prior Fiscal Year
Total Assets $0.00 $0.00
Cash and Cash Equivalents $183,622.00 $1,195.00
Accounts Receivable $0.00 $0.00
Short-term Debt $45,285.00 $32,154.00
Long-term Debt $386,766.00 $0.00

Complete Reg CF filings list for Bioclonetics Immunotherapeutics, Inc.

  • [2018-11-06T13:24:48+00:00] Bioclonetics Immunotherapeutics, Inc. filed a fundraising progress report (Form C-U) with the following update: "The final number is $386,766.00 in investments."

    File number: 020-23900

  • [2018-08-28T13:28:51+00:00] Bioclonetics Immunotherapeutics, Inc. filed an amended Form C (Form C/A) regarding their offering to raise a target of $10,000.00 via StartEngine. The nature of the amendment was described as follows:

    Issuer is extending their campaign.

    File number: 020-23900

  • [2018-06-28T15:38:18+00:00] Bioclonetics Immunotherapeutics, Inc. filed an amended Form C (Form C/A) regarding their offering to raise a target of $10,000.00 via StartEngine. The nature of the amendment was described as follows:

    Issuer is extending their campaign, raising their maximum funding goal, and updating their financials.

    File number: 020-23900

  • [2018-05-25T16:28:33+00:00] Bioclonetics Immunotherapeutics, Inc. filed a Form C-AR.

    File number: 020-23301

  • [2018-04-26T18:45:15+00:00] Bioclonetics Immunotherapeutics, Inc. filed an amended Form C (Form C/A) regarding their offering to raise a target of $10,000.00 via StartEngine. The nature of the amendment was described as follows:

    Issuer is extending their campaign and updating their financials.

    File number: 020-23900

  • [2018-04-03T17:52:01+00:00] Bioclonetics Immunotherapeutics, Inc. filed an amended Form C (Form C/A) regarding their offering to raise a target of $10,000.00 via StartEngine. The nature of the amendment was described as follows:

    Update to offering document due to xml filing error.

    File number: 020-23900

  • [2018-03-27T13:44:54+00:00] Bioclonetics Immunotherapeutics, Inc. filed an amended Form C (Form C/A) regarding their offering to raise a target of $10,000.00 via StartEngine. The nature of the amendment was described as follows:

    Issuer is extending, adjusting their minimum purchase price, and updating the terms of their offering.

    File number: 020-23900

  • New Filing Form C

    [2018-01-04T20:13:20+00:00] Bioclonetics Immunotherapeutics, Inc. filed a Form C to raise a target amount of $10,000.00 (up to a maximum of $148,234.00) of Convertible Note via StartEngine.

    File number: 020-23900

  • [2017-12-01T20:54:03+00:00] Bioclonetics Immunotherapeutics, Inc. filed a fundraising progress report (Form C-U) with the following update: "The final number is $386,766.00 in investments."

    File number: 020-23301

  • [2017-11-06T20:10:44+00:00] Bioclonetics Immunotherapeutics, Inc. filed a fundraising progress report (Form C-U) with the following update: "The final number is $386,766.00 in investments."

    File number: 020-23301

  • [2017-08-31T18:45:11+00:00] Bioclonetics Immunotherapeutics, Inc. filed an amended Form C (Form C/A) regarding their offering to raise a target of $200,000.00 via Wefunder. The nature of the amendment was described as follows:

    Personnel changes, updated disclosures regarding Dr. Joseph Cotropia medical license being revoked, and updated business plan.

    File number: 020-23301

  • New Filing Form C

    [2017-04-10T21:22:05+00:00] Bioclonetics Immunotherapeutics, Inc. filed a Form C to raise a target amount of $200,000.00 (up to a maximum of $1,000,000.00) of Convertible Note via Wefunder.

    File number: 020-23301